BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28975891)

  • 1. Local immune response in cutaneous basal cell carcinoma.
    Omland SH
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer associated fibroblasts (CAFs) are activated in cutaneous basal cell carcinoma and in the peritumoural skin.
    Omland SH; Wettergren EE; Mollerup S; Asplund M; Mourier T; Hansen AJ; Gniadecki R
    BMC Cancer; 2017 Oct; 17(1):675. PubMed ID: 28987144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive Environment in Basal Cell Carcinoma: The Role of Regulatory T Cells.
    Omland SH; Nielsen PS; Gjerdrum LM; Gniadecki R
    Acta Derm Venereol; 2016 Nov; 96(7):917-921. PubMed ID: 27117439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High diversity of the T-cell receptor repertoire of tumor-infiltrating lymphocytes in basal cell carcinoma.
    Omland SH; Hamrouni A; Gniadecki R
    Exp Dermatol; 2017 May; 26(5):454-456. PubMed ID: 27714856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
    Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
    Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated Fibroblasts Affect Intratumoral CD8
    Kato T; Noma K; Ohara T; Kashima H; Katsura Y; Sato H; Komoto S; Katsube R; Ninomiya T; Tazawa H; Shirakawa Y; Fujiwara T
    Clin Cancer Res; 2018 Oct; 24(19):4820-4833. PubMed ID: 29921731
    [No Abstract]   [Full Text] [Related]  

  • 7. Human basal cell carcinoma is associated with Foxp3+ T cells in a Th2 dominant microenvironment.
    Kaporis HG; Guttman-Yassky E; Lowes MA; Haider AS; Fuentes-Duculan J; Darabi K; Whynot-Ertelt J; Khatcherian A; Cardinale I; Novitskaya I; Krueger JG; Carucci JA
    J Invest Dermatol; 2007 Oct; 127(10):2391-8. PubMed ID: 17508019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous and oral squamous cell carcinoma-dual immunosuppression via recruitment of FOXP3+ regulatory T cells and endogenous tumour FOXP3 expression?
    Schipmann S; Wermker K; Schulze HJ; Kleinheinz J; Brunner G
    J Craniomaxillofac Surg; 2014 Dec; 42(8):1827-33. PubMed ID: 25087653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.
    Sasaki K; Sugai T; Ishida K; Osakabe M; Amano H; Kimura H; Sakuraba M; Kashiwa K; Kobayashi S
    Hum Pathol; 2018 Sep; 79():1-8. PubMed ID: 29555579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of IL6-positive Cancer-associated Fibroblasts in Merkel Cell Carcinoma Pathogenesis: A Possible Modulator of Immune Microenvironment.
    Zheng Z; Yoo DS; Li S; Pei M; Lee SG; Kim JY; Chung KY; Roh MR
    Anticancer Res; 2022 Sep; 42(9):4359-4369. PubMed ID: 36039447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity.
    Grund-Gröschke S; Ortner D; Szenes-Nagy AB; Zaborsky N; Weiss R; Neureiter D; Wipplinger M; Risch A; Hammerl P; Greil R; Sibilia M; Gratz IK; Stoitzner P; Aberger F
    Mol Oncol; 2020 Sep; 14(9):1930-1946. PubMed ID: 32615027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-Like Receptor 7 Staining in Malignant Epithelial Tumors.
    Franz R; Ritter N; Hein R; Biedermann T; Al-Sisi M; Eyerich K; Garzorz-Stark N; Andres C
    Am J Dermatopathol; 2017 Oct; 39(10):742-746. PubMed ID: 28857981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell receptor repertoire of lymphocytes infiltrating cutaneous melanoma is predominated by V alpha specificities present in T-cells of normal human skin.
    Strohal R; Paucz L; Pehamberger H; Stingl G
    Cancer Res; 1994 Sep; 54(17):4734-9. PubMed ID: 8062272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A morphological and immunophenotypic map of the immune response in Merkel cell carcinoma.
    Walsh NM; Fleming KE; Hanly JG; Dakin Hache K; Doucette S; Ferrara G; Cerroni L
    Hum Pathol; 2016 Jun; 52():190-6. PubMed ID: 26980039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression.
    Laplagne C; Domagala M; Le Naour A; Quemerais C; Hamel D; Fournié JJ; Couderc B; Bousquet C; Ferrand A; Poupot M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished CD68
    Zhao X; Ding L; Lu Z; Huang X; Jing Y; Yang Y; Chen S; Hu Q; Ni Y
    Am J Pathol; 2020 Apr; 190(4):886-899. PubMed ID: 32035062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments.
    Pellegrini C; Orlandi A; Costanza G; Di Stefani A; Piccioni A; Di Cesare A; Chiricozzi A; Ferlosio A; Peris K; Fargnoli MC
    PLoS One; 2017; 12(8):e0183415. PubMed ID: 28829805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response.
    Kim J; Modlin RL; Moy RL; Dubinett SM; McHugh T; Nickoloff BJ; Uyemura K
    J Immunol; 1995 Aug; 155(4):2240-7. PubMed ID: 7636270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The crosstalk: Tumor-infiltrating lymphocytes rich in regulatory T cells suppressed cancer-associated fibroblasts.
    Fu Z; Zuo Y; Li D; Xu W; Li D; Chen H; Zheng S
    Acta Oncol; 2013 Nov; 52(8):1760-70. PubMed ID: 23336253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
    Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
    J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.